Cas no 186743-06-6 (Tert-Butyl (4-oxobutan-2-yl)carbamate)
Tert-Butyl (4-oxobutan-2-yl)carbamate Chemical and Physical Properties
Names and Identifiers
-
- Carbamic acid,(1-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI)
- tert-Butyl (4-oxobutan-2-yl)carbamate
- Carbamic acid, (1-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI)
- tert-butyl N-(4-oxobutan-2-yl)carbamate
- Butanal, 3-[(tert-butyloxycarbonyl)amino]-
- GIQHYOAEOMSKKV-UHFFFAOYSA-N
- AK451378
- AK441668
- tert-Butyl 1-methyl-3-oxopropylcarbamate #
- (S)-tert-Butyl (4-oxobutan-2-yl)carbamate
- tert-butyl N-(1-methyl-3-oxo-propyl)carbamate
- tert-butyl N-(4-oxidanylidenebutan-2-yl)carbamate
- N-(4-oxobutan-2-yl)carbamic acid tert-butyl ester
- N-(3-keto-1-methyl-propyl)carbamic
- SB44252
- (R)-3-(Boc-amino)butanal
- SY254266
- SY254267
- MFCD18835622
- tert-Butyl(4-oxobutan-2-yl)carbamate
- MFCD24468160
- SCHEMBL73696
- (S)-3-(Boc-amino)butanal
- MFCD30162643
- DS-18807
- 186743-06-6
- AKOS027401307
- C73586
- (S)-tert-Butyl(4-oxobutan-2-yl)carbamate
- Tert-Butyl (4-oxobutan-2-yl)carbamate
-
- MDL: MFCD24468160
- Inchi: 1S/C9H17NO3/c1-7(5-6-11)10-8(12)13-9(2,3)4/h6-7H,5H2,1-4H3,(H,10,12)
- InChI Key: GIQHYOAEOMSKKV-UHFFFAOYSA-N
- SMILES: O(C(NC(C)CC=O)=O)C(C)(C)C
Computed Properties
- Exact Mass: 187.12091
- Monoisotopic Mass: 187.12084340g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 13
- Rotatable Bond Count: 5
- Complexity: 184
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 55.4
- XLogP3: 0.8
Experimental Properties
- PSA: 55.4
Tert-Butyl (4-oxobutan-2-yl)carbamate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B894670-250mg |
tert-Butyl (4-oxobutan-2-yl)carbamate |
186743-06-6 | 97% | 250mg |
2,680.20 | 2021-05-17 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | T40910-1g |
tert-Butyl (4-oxobutan-2-yl)carbamate |
186743-06-6 | 97% | 1g |
¥7146.0 | 2024-07-18 | |
| eNovation Chemicals LLC | D958873-250mg |
Carbamic acid, (1-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) |
186743-06-6 | 97% | 250mg |
$225 | 2024-06-06 | |
| Chemenu | CM220132-1g |
tert-Butyl (4-oxobutan-2-yl)carbamate |
186743-06-6 | 97% | 1g |
$*** | 2023-03-29 | |
| abcr | AB528380-250mg |
tert-Butyl (4-oxobutan-2-yl)carbamate; . |
186743-06-6 | 250mg |
€815.40 | 2025-04-20 | ||
| abcr | AB528380-250 mg |
tert-Butyl (4-oxobutan-2-yl)carbamate; . |
186743-06-6 | 250MG |
€803.10 | 2023-07-10 | ||
| 1PlusChem | 1P00AWY6-250mg |
Carbamic acid, (1-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) |
186743-06-6 | 97% | 250mg |
$578.00 | 2024-06-17 | |
| 1PlusChem | 1P00AWY6-1g |
Carbamic acid, (1-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI) |
186743-06-6 | 97% | 1g |
$1389.00 | 2024-06-17 | |
| A2B Chem LLC | AF08462-250mg |
tert-Butyl (4-oxobutan-2-yl)carbamate |
186743-06-6 | 97% | 250mg |
$498.00 | 2024-04-20 | |
| A2B Chem LLC | AF08462-1g |
tert-Butyl (4-oxobutan-2-yl)carbamate |
186743-06-6 | 97% | 1g |
$1207.00 | 2024-04-20 |
Tert-Butyl (4-oxobutan-2-yl)carbamate Related Literature
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
Additional information on Tert-Butyl (4-oxobutan-2-yl)carbamate
Introduction to Tert-Butyl (4-oxobutan-2-yl)carbamate (CAS No. 186743-06-6)
Tert-Butyl (4-oxobutan-2-yl)carbamate, with the chemical formula C9H14O3 and a CAS number of 186743-06-6, is a significant compound in the field of organic chemistry and pharmaceutical research. This compound, often referred to by its systematic name, has garnered attention due to its unique structural properties and potential applications in various chemical synthesis processes.
The molecular structure of Tert-Butyl (4-oxobutan-2-yl)carbamate consists of a carbamate functional group attached to a tert-butyl group, which is linked to a 4-oxobutane moiety. This specific arrangement imparts distinct reactivity and stability characteristics, making it a valuable intermediate in the synthesis of more complex molecules. The presence of the carbamate group suggests potential utility in the development of bioactive compounds, particularly in the realm of drug design and molecular recognition.
In recent years, there has been growing interest in the application of Tert-butyl (4-oxobutan-2-yl)carbamate in medicinal chemistry. Researchers have been exploring its role as a building block for the synthesis of novel therapeutic agents. The tert-butyl group, known for its steric hindrance properties, can influence the conformational flexibility of the resulting molecules, which is crucial for optimizing pharmacokinetic profiles. Furthermore, the carbamate moiety is frequently employed in the development of protease inhibitors and other enzyme-targeted drugs.
One of the most compelling aspects of Tert-butyl (4-oxobutan-2-yl)carbamate is its versatility in synthetic chemistry. It can serve as a precursor for various derivatives, allowing chemists to tailor its properties for specific applications. For instance, it has been utilized in the preparation of chiral intermediates, which are essential for creating enantiomerically pure drugs with enhanced efficacy and reduced side effects.
The compound's stability under various reaction conditions makes it an attractive choice for industrial-scale synthesis. Its resistance to hydrolysis and oxidation ensures that it remains intact throughout multi-step synthetic pathways, thereby improving overall yield and purity. These attributes have positioned Tert-butyl (4-oxobutan-2-yl)carbamate as a cornerstone in many synthetic protocols.
Recent advancements in computational chemistry have further highlighted the importance of Tert-butyl (4-oxobutan-2-yl)carbamate. Molecular modeling studies have revealed insights into its interaction with biological targets, providing a foundation for rational drug design. By leveraging these computational tools, researchers can predict how this compound might behave within complex biological systems, thereby accelerating the discovery process.
The pharmaceutical industry has also taken notice of Tert-butyl (4-oxobutan-2-yl)carbamate's potential. Several companies are currently investigating its use in developing new treatments for various diseases. Its structural features make it a promising candidate for modulating biological pathways associated with inflammation, neurodegeneration, and cancer. Early-stage clinical trials are underway to assess its safety and efficacy in human subjects.
In addition to its pharmaceutical applications, Tert-butyl (4-oxobutan-2-yl)carbamate finds utility in agrochemical research. Its derivatives have shown promise as herbicides and fungicides due to their ability to disrupt essential metabolic pathways in plants. This dual functionality underscores the compound's broad applicability across multiple scientific disciplines.
The synthesis of Tert-butyl (4-oxobutan-2-y l)carbamate involves well-established organic reactions, including condensation and alkylation processes. These reactions are typically carried out under controlled conditions to ensure high yields and minimal byproduct formation. Advances in green chemistry principles have also led to the development of more sustainable synthetic routes, reducing environmental impact while maintaining efficiency.
The future prospects for Tert-butyl (4-o xobutan -2-y l)carbamate are promising, with ongoing research aimed at expanding its applications further. Innovations in synthetic methodologies and drug discovery technologies will continue to drive its use in developing novel compounds with therapeutic potential. As our understanding of molecular interactions deepens, this compound is likely to play an increasingly vital role in addressing global health challenges.
186743-06-6 (Tert-Butyl (4-oxobutan-2-yl)carbamate) Related Products
- 403712-71-0(Carbamic acid,(1,2-dimethyl-3-oxopropyl)-, 1,1-dimethylethyl ester (9CI))
- 52815-19-7(Boc-dl-3-aminobutyric acid)
- 497861-77-5(tert-butyl N-(2R)-4-oxobutan-2-ylcarbamate)
- 181646-38-8(tert-Butyl 2-Methyl-4-oxobutan-2-ylcarbamate)
- 118173-26-5(Carbamic acid, (1-methyl-3-oxopropyl)-, 1,1-dimethylethyl ester, (S)-)
- 644991-42-4(Tert-butyl (4-methyl-1-oxopentan-3-yl)carbamate)
- 159991-23-8((R)-3-(tert-Butoxycarbonylamino)butanoic Acid)
- 154748-49-9(tert-butyl N-(3-oxocyclobutyl)carbamate)
- 280758-01-2(Carbamic acid,[(1S)-2-methyl-1-(2-oxoethyl)propyl]-, 1,1-dimethylethyl ester (9CI))
- 198493-29-7(Carbamic acid, [(1R)-1-ethyl-3-oxopropyl]-, 1,1-dimethylethyl ester (9CI))